12 Marijuana Stocks to Buy Now

Posted on Wednesday, March 9th, 2022 by MarketBeat Staff

There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren’t directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.

Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some “marijuana stocks” are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.

This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.

#1 – Canopy Growth (TSE:WEED)

MarketBeat Followers 2,777

Market Cap C$3.18 billion

Consensus Rating Hold

Rating Score 1.8

Ratings Breakdown 3 Buy Ratings, 4 Hold Ratings, 5 Sell Ratings.

Consensus Price Target C$13.08 (61.8% Upside)

Canopy Growth logoCanopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.Read More 

 

Recent Analyst Ratings

#2 – Innovative Industrial Properties (NYSE:IIPR)

MarketBeat Followers 1,653

Market Cap $4.68 billion

Consensus Rating Buy

Rating Score 2.8

Ratings Breakdown 4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.

Consensus Price Target $268.17 (46.8% Upside)

Innovative Industrial Properties logoInnovative Industrial Properties, Inc is a real estate investment trust, which engages in the acquisition, ownership, and management of industrial properties. It operates through the following geographical segments: Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New York, North Dakota, Ohio, and Pennsylvania.Read More 

 

Recent Analyst Ratings

MarketBeat Followers 1,549

Market Cap $44.15 million

Consensus Rating N/A

Rating Score NaN

Ratings Breakdown 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.

Consensus Price Target N/A

Unrivaled Brands logoTerra Tech Corp. cultivates, produces, and retails medical and adult use cannabis products. The company also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities in California and Nevada under the Blüm name in California and Nevada. Terra Tech Corp. was founded in 2010 and is based in Santa Ana, California.

 

Recent Analyst Ratings

MarketBeat Followers 1,325

Consensus Rating N/A

Rating Score NaN

Ratings Breakdown 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.

Consensus Price Target N/A

Cannabis Science logoCannabis Science, Inc, together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance.Read More 

 

Recent Analyst Ratings

#5 – 22nd Century Group (NASDAQ:XXII)

MarketBeat Followers 1,299

Market Cap $353.58 million

Consensus Rating Buy

Rating Score 3.0

Ratings Breakdown 3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.

Consensus Price Target $6.50 (199.5% Upside)

22nd Century Group logo22nd Century Group, Inc is a biotechnology company, which develops disruptive plant-based solutions for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques.Read More 

 

Recent Analyst Ratings

#6 – OrganiGram (TSE:OGI)

MarketBeat Followers 1,174

Market Cap C$554.85 million

Consensus Rating Hold

Rating Score 2.0

Ratings Breakdown 2 Buy Ratings, 5 Hold Ratings, 2 Sell Ratings.

Consensus Price Target C$3.48 (96.6% Upside)

OrganiGram logoOrganigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co, ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market.Read More 

 

Recent Analyst Ratings

MarketBeat Followers 1,144

Market Cap $110.83 million

Consensus Rating Buy

Rating Score 3.0

Ratings Breakdown 1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.

Consensus Price Target $2.00 (187.8% Upside)

KushCo logoKushCo Holdings, Inc provides ancillary products and services to the legal cannabis and cbd cream industries. The firm through its subsidiaries and brands provides product quality, exceptional customer service, compliance knowledge and a local presence in serving diverse customer base. The company was founded by Dallas Imbimbo, John Kovacevich, Nicholas Kovacevich, and Jeffrey Meng on December 15, 2010 and is headquartered in Cypress, CA.

 

Recent Analyst Ratings

#8 – Medical Marijuana (OTCMKTS:MJNA)

MarketBeat Followers 1,026

Consensus Rating N/A

Rating Score NaN

Ratings Breakdown 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.

Consensus Price Target N/A

Medical Marijuana logoMedical Marijuana, Inc engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. It operates through the following divisions: Medical Marijuana Inc, HempMeds and Kannaway. Medical Marijuana Inc operates as the parent company of all divisions. HempMeds distributes hemp oil in the US and internationally.Read More 

 

Recent Analyst Ratings

MarketBeat Followers 973

Market Cap $508.45 million

Consensus Rating Buy

Rating Score 2.5

Ratings Breakdown 4 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.

Consensus Price Target $21.56 (152.8% Upside)

GrowGeneration logoGrowGeneration Corp. engages in the retail of hydroponic and organic specialty gardening products. It offers lighting fixtures, nutrients, seeds and growing media systems, trays, fans, filters, humidifiers and dehumidifiers, timers, instruments, water pumps, irrigation supplies, and hand tools. The company was founded by Darren Lampert and Michael Salaman on March 6, 2014 and is headquartered in Denver, CO.

 

Recent Analyst Ratings

#10 – Marijuana Company of America (OTCMKTS:MCOA)

MarketBeat Followers 829

Consensus Rating N/A

Rating Score NaN

Ratings Breakdown 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.

Consensus Price Target N/A

Marijuana Company of America logoMarijuana Company of America, Inc engages in the investment in a portfolio of legal cannabis and industrial hemp businesses. It operates through the hempSMART segment. The company was founded on October 4, 1985 and is headquartered in Los Angeles, CA.

 

Recent Analyst Ratings

MarketBeat Followers 570

Consensus Rating N/A

Rating Score NaN

Ratings Breakdown 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.

Consensus Price Target N/A

Cannabis Sativa logoCannabis Sativa, Inc operates as a pharmaceutical company. The firm develops, manufactures, and sells herbal based skin care products in the United States and internationally. It offers Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain, Trauma Cream, a cream for blended infusion of cannabinoids and THC, Face Garden, an antioxidant moisturizing cream for the face, Body Garden, a moisturizing body lotion, and Lip Garden, an emollient balm.Read More 

 

Recent Analyst Ratings

MarketBeat Followers 503

Market Cap $1.55 million

Consensus Rating N/A

Rating Score NaN

Ratings Breakdown 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.

Consensus Price Target N/A

United Cannabis logoUnited Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy.Read More 

 

Recent Analyst Ratings

 

Top Ten Brokerages You Can Trust

There are more than 500 brokerages and research houses that hire analysts to issue ratings and recommendations. Collectively, these brokerages and their analysts publish approximately 250,000 ratings each year. Every trading day, there are nearly 700 reports and recommendations that are released to the public. To say that it’s difficult to separate the signal from the noise when interpreting this data would be an understatement.

MarketBeat has developed a system to track each brokerage and research house’s stock recommendations and score them based on their past performance. If Goldman Sachs predicted that Apple’s stock price would hit $150.00 on a specific date, how accurate were they? If Bank of America issued a “strong-buy” rating on a stock, how did that stock perform compared to the broader market over the following twelve months? This tracking system has been applied to the 1,000,000+ ratings that MarketBeat has tracked during the last ten years to identify which brokerages you can really trust (and which you can safely ignore).

This slide show lists the 10 brokerages who have issued the most accurate analyst recommendations over the past several years, as measured by the performance of their “buy” ratings and the accuracy of their price targets.

View the “Top Ten Brokerages You Can Trust” Here.

‘);]]>

(Visited 1 times, 1 visits today)